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ABSTRACT
Motivation: Given multi-platform genome data with prior knowl-
edge of functional gene sets, how can we extract interpretable latent
relationships between patients and genes? More specifically, how
can we devise a tensor factorization method which produces an
interpretable gene factor matrix based on gene set information
while maintaining the decomposition quality and speed?
Method:WeproposeGIFT, aGuided and Interpretable Factorization
for Tensors. GIFT provides interpretable factor matrices by encod-
ing prior knowledge as a regularization term in its objective func-
tion.
Results: Experiment results demonstrate that GIFT produces in-
terpretable factorizations with high scalability and accuracy, while
other methods lack interpretability. We apply GIFT to the PanCan12
dataset, and GIFT reveals significant relations between cancers,
gene sets, and genes, such as influential gene sets for specific can-
cer (e.g., interferon-gamma response gene set for ovarian cancer) or
relations between cancers and genes (e.g., BRCA cancer↔ APOA1
gene and OV, UCEC cancers↔ BST2 gene).
Availability: The code and datasets used in the paper are available
at https://github.com/leesael/GIFT.
Contact: sael@cs.stonybrook.edu
1 INTRODUCTION
Increasing number of multi-platform genome data of a single per-
son, such as a cancer patient, are being generated. These data
describe different biological aspects of a person and need to be
integratively analyzed to obtain a holistic view. However, due to
the complexity of the problem, the results of existing methods are
difficult to interpret and often do not scale to larger data [37]. In-
terpretability of the results obtained by the methods is important
as most bio-medical studies focus on discoveries. Scalability of an
analysis method is also important as the number of data increases.
1.1 Integrative Genomic Data Analysis for
Cancer Studies
The Cancer Genome Atlas (TCGA) have reported several integrated
genome-wide studies of cancer data. In 2013, TCGA published the
PanCan12 dataset that includes multi-platform genomic informa-
tion of 12 tumor types [44]. The dataset has boosted many genomic
cancer analyses [3, 32] including the TCGA original multi-platform
data analysis [12]. [12] utilizes cluster-of-cluster analysis (COCA)
approach for stratification of the Pancan12 dataset. The COCA is a
∗These authors contributed equally to this work.
two-step approach that clusters against cluster results of individual
data types. Although the method is applicable for large data, the
two-step process makes it difficult to trace back and interpret the
results. Multi-kernel approaches are also a multi-step approach that
the first generates individual kernels from each data type, the sec-
ond learns a multi-kernel, and the third applies the multi-kernel to
cluster or classify [38]. Although kernel-based methods are highly
accurate, interpretability is lost in the generation of the kernels.
Another integrative method widely used by TCGA is PARADIGM
[12, 17, 40]. The method is based on Bayesian network inference
and is dependent on the biological pathway used and protein ex-
pression data. Due to these requirements, it is often applied to a
small number of genes.
1.2 Matrix/Tensor Mining Methods
Matrix factorization methods, such as the non-negative matrix
factorization (NMF), are broadly used across multiple domains, in-
cluding a bio-data analysis, to analyze data represented as matrices.
NMF was also used extensively by the TCGA group [12, 17, 20] and
others [13, 18, 46] for studying single-platform genome analyses
such as somatic mutations or gene expressions.
Natural extensions of single data type modeled as matrices to multi-
platform data type are tensors, i.e., multi-dimensional arrays. Ten-
sors are widely applied to represent many real-world data such as
movie rating and network traffic data expressed as 3-order tensors
with (movie - user - time) and (source IP - destination IP - time)
triples, respectively. Multi-platform genome data can also be rep-
resented as a 3-order tensor that contains the experiment values
indexed with (patient - gene - experimental platform).
Tensor factorization (TF) methods are applied to analyze tensor
data just as matrix factorization methods are used for analyzing
matrices. TF decomposes a given tensor into factor matrices and
a core tensor that contains latent relationships between original
components. Applications of TF include anomaly detection from
network traffic data [9], healthcare monitoring from sensor data
[43], fraud detection from social network data, and biomedical data
[7, 19].
However, tensor factorization methods have not been extensively
applied to genomic data mainly due to scalability, missing data
problem, and interpretability. For example, the PanCan12 dataset
forms a 3-order tensor of size 4, 555 × 14, 351 × 5. A regular ten-
sor decomposition method will not run due to intermediate data
explosion that occurs in the calculation [16]. We have previously
addressed the scalability and missing data problems [5, 30, 34] and
various ways to exploit prior knowledge to obtain high-quality
factorizations or intended latent patterns [5, 6, 15, 24]. However,
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Figure 1: An overview of GIFT, Silenced-TF, and P-Tucker. All methods are based on a Tucker factorization, which decom-
poses a given tensor into a core tensor and factor matrices. P-Tucker results in dense gene factor matrices. Silenced-TF
and GIFT result in sparse factor matrices. Silenced-TF puts hard constraints while GIFT puts soft constraints based on prior
knowledge.
factor matrices produced by existing methods are hard to interpret
due to their density and unclear value distributions.
Developing an interpretable TF method is essential for analyzing
its resultant factors more effectively; poor interpretability makes
it hard to discover latent patterns. The main challenge is to make
factor matrices interpretable while preserving the TF accuracy. Our
goal is to devise an interpretable TF method for partially observed
tensors exploiting prior knowledge while preserving the accuracy
and scalability.
1.3 Contributions
Table 1: Comparison of GIFT and the other algorithms.GIFT
produces interpretable results while maintaining high accu-
racy and scalability. However, P-Tucker and Silenced-TF
lack interpretability or accuracy, respectively.
Method P-Tucker [30] Silenced-TF GIFT
Interpretability ✓ ✓
Accuracy ✓ ✓
Scalability ✓ ✓ ✓
Our main contributions are as follows.
• Method.We propose GIFT (Guided and Interpretable Factor-
ization for Tensors) that outputs interpretable factor matrices
by constraining the factor matrices based on prior knowledge.
• Experiments.We validate that GIFT is not only interpretable
but highly scalable and accurate (Table 1).
• Discovery.We applyGIFT to large-scale multi-platform cancer
genome analysis using the PanCan12 dataset and show how
the method easily and successfully discovers significant rela-
tions between genes, gene sets, and patients, as summarized in
Table 4.
2 METHODS
In this section, we describe datasets used, preliminaries of tensors,
and proposed methods. Preliminaries contain tensor basics and a
brief description of our baseline approach P-Tucker [30] that we
have recently proposed. In the proposed methods, we first describe
naive interpretable approach Silenced-TF and then suggest more
advanced method GIFT.
2.1 Data Processing
We use PanCan12 [44] and Hallmark gene set data from MSigDB
[25] collections as an input tensor and a mask matrix, respectively.
Table 2 summarizes the data we used in this paper.
Table 2: Summary of datasets used for experiments. M: mil-
lion, K: thousand.
Dataset Order Dimension Observable Entries
PANCAN12 tensor 3 (4555, 14351, 5) 180M
Sampled-PANCAN12 3 (4555, 14351, 5) 36−144M
Mask matrixM(2) 2 (14351, 50) 7K
2.1.1 Mask Matrix. We generate a gene group mask matrix
M(2) in a form of (gene - gene set) using the Hallmark data, which
contain 50 important gene sets. Each column of mask matrixM(2)
corresponds to a gene set. If a gene in is contained in a gene set
jn then it is unmasked, i.e., M(2)in jn is set to 0; otherwise, the gene
is masked, i.e., set to 1. If no prior-knowledge is known, the mask
matrices are set to zero matrices with the size of corresponding
factor matrices.
2.1.2 PanCan12 Tensor. The PanCan12 dataset is represented as
a 3-order tensor in a form of (patient - gene - platform; experiment
value). Initially, the 4.7 version of the PanCan12 was downloaded
from the Sage Bionetworks repository, Synapse [31]. The PanCan12
contains multi-platform data with mapped clinical information of
patients group into cohorts of twelve cancer type: bladder urothe-
lial carcinoma (BLCA), breast adenocarcinoma (BRCA), colon and
rectal carcinoma (COAD, READ), glioblastoma multiforme (GBM),
head and neck squamous cell carcinoma (HNSC), kidney renal clear
cell carcinoma (KIRC), acute myeloid leukemia (LAML), lung adeno-
carcinoma (LUAD), lung squamous cell carcinoma (LUSC), ovarian
serous carcinoma (OV), and uterine corpus endometrial carcinoma
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(UCEC). After download, probes of each platform are mapped to
corresponding gene symbols. Then, subjects that have less than two
evidence are removed from the dataset and genes that are not part
of Hallmark set are removed. The resulting data for each platform
are min-max normalized and is further normalized such that the
Frobenius norm, i.e.,∥A∥ ≡
√∑
i
∑
j |ai j |2.
2.2 Tensor Preliminaries
In this section, we describe preliminaries of a tensor and its factor-
ization methods. Table 3 summarizes symbols used in this paper.
Table 3: Table of symbols.
Symbol Definition
X tensor (Euler script, bold letter)
X matrix (uppercase, bold letter)
x scalar (lower case, italic letter)
N order (number of modes) of a tensor
In, Jn dimensionality of the nth mode of input and core tensor
A(n) nth factor matrix (∈ RIn×Jn )
a(n)in jn (in, jn )th entry of A(n)
Ω set of observable entries of X
|Ω |, |G | number of observable entries of input and core tensor
λ regularization parameter for factor matrices
| | • | |F Frobenius norm
∗ element-wise multiplication
◦ outer product
×n n-mode product
2.2.1 Tensor. A tensor is a multi-dimensional array which is a
generalization of a matrix and a vector. A mode or a way indicates
each axis of a tensor, and an order is the number of modes or ways.
We denote a tensor using boldface Euler script letters (e.g., X). A
tensor X ∈ RI1×I2×···×IN is an N -order tensor which has N modes
whose lengths are from I1 to IN . A vector and a matrix are regarded
as a 1- and a 2-order tensor, respectively. We denote a matrix and a
vector using boldface uppercase (e.g., X) and lowercase letters (e.g.,
x), respectively. The i1th row of A is denoted by ai1:, and the i2th
column of A is denoted by a:i2 .
2.2.2 Tensor Decomposition. Among many tensor decomposi-
tion methods, we use Tucker factorization [8, 39] methods, which
allows us to discover not only latent concepts but also relations
between the concepts hidden in tensors [30]. Tucker factorization
decomposes a given tensorX into a core tensor G and factor matri-
ces A(1), · · · ,A(N ), as defined in Definition 2.1.
Definition 2.1. (Tucker factorization)Given a tensorX ∈ RI1×I2×···×IN ,
the Tucker factorization of rank (J1, · · · , JN ) finds a core tensorG ∈
RJ1×···×JN and factor matrices A(1) ∈ RI1×J1 , · · · ,A(N ) ∈ RIN ×JN ,
which minimize the following objective function (1).
L(G, A(1), · · · , A(N ))
= | |X −
∑
∀(j1, . . ., jN )∈G
Gj1, . . ., jN (a(1)j1 ◦ · · · ◦ a
(N )
jN
) | |2F
=
∑
∀(i1, . . .,iN )∈X
(
X(i1, . . .,iN ) −
∑
∀(j1, . . ., jN )∈G
G(j1, . . ., jN )
N∏
n=1
a(n)in jn
)2 (1)
Note that Equation (1) assumes missing entries of X as zeros. Each
column vector of a factor matrix generally represents each different
concept. A higher value in a vector indicates that the corresponding
element is highly related to the concept. Assuming a given tensor is
movie rating data with (movie - user - time) triples, then a column
vector in a movie-factor matrix can have a concept such as a horror
or comic genre.
2.2.3 Partially Observable Tensor Factorization. Many real-world
tensors have missing values in them (i.e. partially observed). Ap-
plying standard Tucker factorization methods to the data triggers
highly inaccurate results since they regard missing entries as zeros.
Partially observable tensor factorization methods focus only on
observed entries to tackle this problem, and a partially observable
Tucker factorization is defined as follows.
Definition 2.2. (PartiallyObservableTucker Factorization)Given
a tensor X ∈ RI1×I2×···×IN with observable entries Ω, a partially
observable Tucker factorization of rank (J1, · · · , JN ) finds a core ten-
sor G ∈ RJ1×···×JN and factor matrices A(1) ∈ RI1×J1 , · · · ,A(N ) ∈
RIN ×JN which minimize the following objective function.
L(G,A(1), · · · ,A(N )) =∑
∀(i1, ...,iN )∈X
(
X(i1, ...,iN ) −
∑
∀(j1, ..., jN )∈G
G(j1, ..., jN )
N∏
n=1
a
(n)
in jn
)2
+ λ
( N∑
n=1
| |A(n) | |2F
)
(2)
Note that λ denotes a regularization parameter for factor matrices,
and we used L2-regularization to prevent overfitting, which has
been widely used in recommender systems [21, 34].
2.2.4 Baseline Approach: P-Tucker. Among many Tucker fac-
torization methods [10, 29, 35], P-Tucker [30] shows the best scal-
ability and accuracy for partially observable tensors by focusing
on observed entries of the tensors. The objective function of P-
Tucker is the same to Equation (2), and P-Tucker uses a row-wise
alternating least squares (ALS) to minimize the loss function. In
detail, P-Tucker first chooses a row of a factor matrix to be updated
while fixing all the others, and it computes three intermediate data
δ
(n)
(i1, ...,iN ), B
(n)
in
, and c(n)in : defined as follows. Notice that IJn is a
Jn × Jn identity matrix.
δ
(n)
(i1, ...,iN ) is a length Jn vector whose jth entry is∑
∀(j1 ...jn=j ...jN )∈G
G(j1 ...jn=j ...jN )
∏
k,n
a
(k )
ik jk
, (3)
B(n)in is a Jn × Jn matrix whose (j1, j2)th entry is∑
∀(i1, ...,iN )∈Ω(n)in
δ
(n)
(i1, ...,iN )(j1)δ
(n)
(i1, ...,iN )(j2), (4)
and c(n)in : is a length Jn vector whose jth entry is∑
∀(i1, ...,iN )∈Ω(n)in
X(i1, ...,iN )δ
(n)
(i1, ...,iN )(j). (5)
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Using the above intermediate data, P-Tucker updates a row a(n)in : by
an update rule c(n)in : ×[B
(n)
in
+λIJn ]−1. After updating factor matrices,
P-Tucker calculates reconstruction error by the following rule.
√√ ∑
∀(i1, . . .,iN )∈Ω
(
X(i1, . . .,iN ) −
∑
∀(j1, . . ., jN )∈G
G(j1, . . ., jN )
N∏
n=1
a(n)in jn
)2
(6)
If the error converges or the maximum iteration is reached, P-
Tucker stops iterations and performs QR decompositions to or-
thogonalize factor matrices and update a core tensor accordingly.
Note that [30] suggests full details and proofs of the update process.
2.3 Proposed Methods
The main challenge is to devise a method which employs prior
knowledge to produce interpretable factors while maintaining the
decomposition quality and speed.
2.3.1 Silenced-TF. Although our previous method P-Tucker
presents high scalability and accuracy, it is hard to interpret the re-
sults of P-Tucker since the factor matrices are dense and there is no
direct interpretable connection between significant components, i.e.
genes in each factor column that describes a group. Silenced-TF lit-
erally silences uninteresting or unnecessary parts of factor matrices
and updates the rest using the same algorithm of P-Tucker.
More specifically, given a tensorX ∈ RI1×I2×···×IN with observable
entries Ω, Silenced-TF of rank (J1, · · · , JN ) finds a core tensor G ∈
RJ1×···×JN and factor matrices A(1) ∈ RI1×J1 , · · · ,A(N ) ∈ RIN ×JN
which minimize the following objective function subjected to mask
matricesM(1) ∈ RI1×J1 , · · · ,M(N ) ∈ RIN ×JN .
minimize
G,A(1), · · · ,A(N )
L(G,A(1), · · · ,A(N ),M(1), · · · ,M(N ))
subject to a(n)in jn = 0 when m
(n)
in jn
= 1
(7)
The difference in Silenced-TF compared to P-Tucker is in the
selective updates of rows of factor matrices. To be more specific,
given themaskmatrices that encode the prior knowledge, Silenced-
TF only updates an entry in the gene factor matrix, a(n)in jn , when the
corresponding masking elementm(n)in jn is 0, and Silenced-TF sets
the entry a(n)in jn in the gene factor matrix as a zero whenm
(n)
in jn
is 1.
By masking, Silenced-TF offers interpretable gene factor matrices
in addition to the benefits offered by P-Tucker: scalability and
applicability for partially observed data.
2.3.2 GIFT. Two potential weaknesses of Silenced-TF are low
factorization accuracy due to many zeros in its factor matrices and
inability to find genes that have a significant relationship to the
gene group if they are specified as a member the gene group. To
address these weaknesses, we propose GIFT which offers inter-
pretability, high accuracy, and flexibility. GIFT tackles the problem
by employing selective regularization of factormatrices.GIFT penal-
ties proportional to λ on masked entries of factor matrices during
the update process. Thus, GIFT makes a distinction between the
values of masked and unmasked genes for each gene group. More-
over, the accuracy of GIFT is similar to P-Tucker since masked
Algorithm 1 GIFT
Input: A tensor X ∈ RI1×···×IN with observable entries Ω, mask matrices
M(1), · · · , M(N ), rank (J1, · · · , JN ), and a regularization parameter λ.
Output: A core tensor G and factor matrices A(1), · · ·A(N ).
1: initialize G and A(1), · · · , A(N ) randomly
2: repeat
3: for n = 1, · · · , N do
4: for in = 1, · · · , In do
5: calculate intermediate data δ , B(n)in , and c
(n)
in : by (3) – (5)
6: calculate D(n)in , where its (jn, jn )th entry isM
(n)
in jn
7: update a row a(n)in : by c
(n)
in : × [B
(n)
in + λD
(n)
in ]−1
8: end for
9: end for
10: compute reconstruction error by (6)
11: until a convergence criterion is met
12: for n = 1...N do
13: A(n) → Q(n)R(n)
14: A(n) ← Q(n)
15: G← G ×n R(n)
16: end for
entries can also have small values unlike the strict zero constraints
of Silenced-TF.
GIFT encodes mask matricesM(n) into its objective function as a
regularization term. The specific loss function of GIFT is given by
the following Equation (8).
L(G,A(1), · · · ,A(N ),M(1), · · · ,M(N )) =∑
∀(i1, ...,iN )∈Ω
(
X(i1, · · · ,iN ) −
∑
∀(j1, ..., jN )∈G
G(j1, · · · , jN )
N∏
n=1
a
(n)
in jn
)2
+ λ
( N∑
n=1
| |M(n) ∗ A(n) | |2
)
(8)
The main difference between P-Tucker and GIFT is an existence of
mask matricesM(n) in a regularization term. GIFT usesM(n) ∗A(n)
instead of justA(n), where ∗ denotes an element-wisemultiplication.
Through the specially-designed regularization, GIFT fully exploits
prior knowledge encoded inM(n). Compared to Silenced-TF, GIFT
shows flexibility regarding the updates of masked entries. Instead of
fixing them as zeros, GIFT imposes regularizations on them, which
tend to make the values smaller, but not normally zeros.
Algorithm 1 describes how GIFT updates given factor matrices.
When GIFT updates a row a(n)in : (line 6), it requires a diagonal matrix
D which reflects masking information (line 5), while P-Tucker uses
an identity matrix IJn . The other parts of GIFT are the similar to that
of P-Tucker. Table 1 shows a comparison of GIFT, Silenced-TF,
and P-Tucker.
3 RESULTS
In this section, we describe experimental results of GIFT compared
to Silenced-TF and P-Tucker. We aim to answer the following
questions.
[Q1] Interpretability: How interpretable are factor matrices pro-
duced by GIFT and the other methods? (Section 3.2)
[Q2] Accuracy: How accurately do GIFT and the other methods
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factorize a given tensor and predict missing entries of the tensor?
(Section 3.3)
[Q3] Scalability: How well do GIFT and the other methods scale
up with respect to the number of observed entries of a tensor?
(Section 3.4)
3.1 Experimental Settings
GIFT, Silenced-TF, and P-Tucker are implemented in C with
OpenMP and Eigen libraries. We run our experiments on a single
machine with 20 cores / 40 threads, equipped with an Intel Xeon
E5-2630 v4 2.2GHz CPU and 512GB RAM. We set the default rank
as (30 × 50 × 2). In reporting running times, we use the average
elapsed time per iteration, not the total running time. Notice that
we use absolute values of factor matrices for all experiments.
3.2 Interpretability
We regard a gene factor matrix as interpretable if the genes com-
posing a gene set (unmasked) have distinguishably larger factor
values than the factor values of genes that are not in the gene set
(masked). In Silenced-TF, this is strictly enforced by making the
factor values of genes that are not in the gene set (masked) are all
set to zeros. In GIFT, this is not strictly enforced. In other words,
there is a potential that factor values of the masked genes become
large and those of the unmasked genes become small. This is likely
to happen only when the prior knowledge and the data do not
agree. However, as presented in Figure 2, GIFT generates a gene
factor matrix within high factor values (larger than 10) for the
subset of unmasked entries (A) and small factor values (less than
1) for a majority of the masked entries (B). This shows that GIFT
has learned the latent relationships of cancer patients to gene sets
and significant genes in the gene set. P-Tucker, on the other hand,
produces a gene factor matrix with value distribution that has small
or no correlation to a gene set (refer to the supplementary material
for the results of Silenced-TF and P-Tucker).
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Figure 2: Distributions of values in a gene factor matrix de-
rived by GIFT (λ = 10) for unmasked (A) and masked (B) en-
tries.
Additionally, top-K ratios can be used as a metric of interpretability.
A top-K ratio indicates how many unmasked entries are included in
total top-K entries (in descending order by values) of a gene factor
matrix, which is defined as follows.
Top-K ratio R (0 ≤ R ≤ 1) = number of unmasked entries in top-K
K
(9)
Figure 3 illustrates top-K ratios. P-Tucker shows the worst top-K
ratios for all K since it does not distinguish unmasked and masked
entries in the calculation. Although Silenced-TF exhibits the high-
est top-K ratios for all K by silencing the masked entries, Silenced-
TF cannot discover important masked entries which are closely
related to unmasked entries since their values are all set to zeros.
Meanwhile, the top-K ratio of GIFT is the highest until K ≤ 102
and decreases rapidly after K ≥ 102 when the important unmasked
entries are saturated and top values start including the unimportant
unmasked entries and important masked entries. Overall, Silenced-
TF and GIFT provide interpretable factorizations with respect to
distributions of values in a factor matrix and top-K ratios.
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Figure 3: Top-K ratios of GIFT and the othermethods. Ahigh
top-K ratio implies that the corresponding method is inter-
pretable.
3.3 Accuracy
We use two evaluation metrics—reconstruction error and test root
means square error (RMSE)—to measure the accuracy. Reconstruc-
tion error indicates an accuracy of a factorization as given in Equa-
tion (6) and test RMSE implies how accurately a method predicts
missing entries of a tensor. To measure test RMSE, we split the
PANCAN12 tensor into training/test data with a ratio of 9 to 1. As
illustrated in Fig. 4A and Fig. 4B, Silenced-TF exhibits the worst
accuracy due to many zeros in a silenced factor matrix. The re-
construction error and test RMSE of Silenced-TF are 15.1× and
6.4× higher than that of P-Tucker when λ = 10 and λ = 0.01, re-
spectively. While P-Tucker shows the best accuracy in most cases,
GIFT presents relatively small accuracy loss compared to that of
Silenced-TF; in particular, test RMSE of GIFT is slightly higher or
even better than that of P-Tucker.
3.4 Scalability
Scalability test is performed by varying the number of observable
entries by randomly sampling 20%, 40%, 60%, 80%, and 100% from the
PANCAN12 tensor. As shown in Fig. 4C, GIFT scales near linearly
in terms of the number of observable entries. We omit results of
P-Tucker and Silenced-TF since they present similar scalability
to that of GIFT (refer to the supplementary material). Note that
computational time and memory usage increase exponentially in
regular tensor decompositions.
3.5 Discovery
In this section, we describe our finding on (cancer - gene sets),
(gene sets - genes), and (cancer - genes) relations hidden in the
PANCAN12 dataset by interpreting results of GIFT with λ = 10.
3.5.1 Cancer to gene sets findings. Given specific cancer type,
which gene set is the most relevant to the cancer type? We first
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Figure 4: Performance comparisons of GIFT, Silenced-TF, and P-Tucker. A is a reconstruction error plot. Silenced-TF is
highly inaccurate due to many zeros in its factor matrix, while GIFT and P-Tucker present a high accuracy. B is a test RMSE
plot. Silenced-TF is highly inaccurate due to many zeros in its factor matrix, while GIFT and P-Tucker present a high
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Table 4: Discoveries on the PANCAN12 dataset via GIFT. GIFT extracts significant gene sets and notable relations between
cancer, gene sets, and genes. Many biological research results substantiate the retrieved relations, which are described in a
gene description column. ( ∗: important gene, −: unimportant gene, +: not included in a gene set, but related).
Cancer Gene set Genes Factor Gene Description
HNSC, LUAD,
LUSC, BLCA TGF beta signaling
SKIL∗ 0.5146 Encodes the SNON, negative regulators of TGF-beta signaling [36].
FKBP1A∗ 0.4692 Interacts with a type I TGF-beta receptor.
LEFTY2∗ 0.2925 Encodes a secreted ligand of the TGF-beta family of proteins.
GBM Angiogenesis
PF4∗ 0.5049 Inhibits cell proliferation and angiogenesis in vitro and in vivo [4].
VCAN∗ 0.4500 Encodes a protein involving in cell adhesion, and angiogenesis [45].
LPL− 0.0429 Encodes lipoprotein lipase [42].
BRCA
Estrogen response
late
IL17RB∗ 0.3807 Involved in development and progression of breast cancer [2].
TFF3∗ 0.3640 Promotes invasion and migration of breast cancer [27].
PTGER3− 0.0200 Encode protein related to digestion and nervous system.
Bile acid
metabolism APOA1
∗ 0.3973 Encodes lipoprotein lipase, an enzyme which hydrolyzes lipoprotein.Known breast cancer risk factor [26].
OV, UCEC
Interferon-gamma
response
IRF7∗ 0.5727 Encodes interferon regulatory factor 7.
BST2∗ 0.4986 High levels of BST2 have been identified in ovarian cancer [33].
SSPN− 0.0983 Associated with a skeletal muscle membrane [23].
Apoptosis CASP8AP2+ 1.4708 Associated with apoptosis of leukemic lymphoblasts [11].
Encoded protein plays a regulatory role in Fas-mediated apoptosis [14].
READ,
COAD
Protein
secretion
STX7∗ 0.4854 Controls vesicle trafficking events involved in cytokine secretion [1].
KIRC,
LAML
Mitotic spindle LATS1∗ 0.4913 Binds phosphorylated zyxin and moves it to the mitotic spindle.
explain our discovery procedure and introduce several examples of
(cancer - gene sets) relations found by GIFT.
We first compute an influence of each gene set on a patient and
extract top-k important gene sets for the patient. After that, we
aggregate all top-k gene sets of patients suffering from the given
cancer and derive top-k relevant gene sets to cancer by choosing
top-k frequent gene sets in aggregations. In detail, a(1)i : is a latent
feature of i-th patient, and G = (∑I3i=1 G::i )/I3 is a relation between
gene sets and columns of a patient-factor matrix. Then, we use
a˜(1)i : = a
(1)
i : G as an influence of each gene set on the i-th patient.
The j-th element of a˜(1)i : indicates the influence of j-th gene set on
the i-th patient. We extract top-k most important gene sets for each
patient by selecting top-k highest values in a˜(1)i : . Finally, we count
the frequency of gene sets that appeared in the top-k gene sets of
all patients of a given cancer type. We regard the most frequent
gene set as the most relevant one to the given cancer.
The first and second columns of Table 4 show (cancer - gene sets)
relations discovered by GIFT. For breast cancer (BRCA), GIFT con-
siders ‘Estrogen response late’ and ‘Bile acid metabolism’ gene sets
closely related to breast cancer. It is well known that the estrogen
plays a key role in the occurrence of breast cancer while the rela-
tion to ‘Bile acid metabolism’ gene set seems unnatural. However,
[28] reveal that patients with breast cancer have significantly low
fecal bile acid concentration than that of controlled patients. For
ovarian cancer (OV), a relation to the ‘Interferon-gamma response’
gene set is supported by [41]. They show that interferon-gamma
causes apoptosis in human epithelial ovarian cancer. The ‘TGF beta
signaling’ gene set is frequent among many types of cancer in-
cluding Head and Neck Squamous Cell Carcinoma (HNSC), Lung
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adenocarcinoma (LUAD), Lung Squamous, Cell Carcinoma (LUSC),
and Bladder carcinoma (BLCA). The reason is that the Transform-
ing growth factor-β (TGF-β) gene set is a tumor suppressor which
affects many types of human cancers [22].
3.5.2 Gene sets to genes findings. Given a gene set, which genes
are important or unimportant within it? Is there a gene not included
but related to the gene set? A high value in the gene factor ma-
trix indicates that the corresponding gene is highly related to the
corresponding gene set. We sort the genes in each column of the
gene factor matrix in descending order by their value and inspect
high-value genes for each gene set.
We show how the discovered (gene sets - genes) relations are sup-
ported by biological facts with examples. The second and third
columns of Table 4 show (gene sets - genes) relations retrieved by
GIFT. The SKIL gene in the ‘TGF beta signaling’ gene set is iden-
tified to be important by GIFT. The SKIL gene encodes a protein
which antagonizes TGF-β signaling [36]. The PF4 gene in the ‘An-
giogenesis’ gene set, reported to be important by GIFT, is known as
an inhibitor of cell proliferation and angiogenesis [4]. The IRF7 gene
in the ‘Interferon-gamma response’ gene set is also identified to be
important, and the gene encodes interferon regulatory factor 7. The
LPL gene in the ‘Angiogenesis’ gene set is unimportant according
to the discovery result of GIFT. The LPL gene encodes lipoprotein
lipase, an enzyme which hydrolyzes lipoprotein [42], thus it has
low relatedness to angiogenesis. GIFT also reports the CASP8AP2
gene is closely related to the ‘Apoptosis’ gene set although the gene
is not included in the gene set. The CASP8AP2 gene is associated
with apoptosis of leukemic lymphoblasts in reality [11].
3.5.3 Cancer to genes findings. Given specific cancer type, which
genes affect the cancer type most? We suggest (cancer - genes) re-
lations by combining two relations (cancer - gene sets) and (gene
sets - genes) discovered by GIFT.
The first and third columns of Table 4 show (cancer - genes) relations
found by GIFT. We regard gene sets in the second column of the
table as bridges for (cancer - genes) relations. We deduce the IL17RB
and TFF3 genes are significant to breast cancer since the genes are
both important for the ‘Estrogen response late’ gene set and the
gene set is the most relevant one to breast cancer. [2] showed that
IL17RB is crucial in development and progression of breast cancer in
effect. Moreover, [27] reveal that the TFF3 gene promotes invasion
and migration of breast cancer. GIFT also finds that the APOA1
gene in the ‘Bile acid metabolism’ gene set is highly related to breast
cancer. High levels of APOA1 are known to be related to increased
breast cancer risk [26]. In the case of ovarian cancer, GIFT asserts a
strong relation to the BST2 gene. High levels of BST2 have been
identified in ovarian cancer [33].
4 DISCUSSIONS AND CONCLUSION
In this paper, we proposed GIFT, a guided and interpretable factor-
izationmethod for tensors.GIFT provides interpretable factor matri-
ces by encoding prior knowledge through selective regularization.
Experiment results demonstrate that GIFT produces interpretable
factorizations with high scalability and accuracy, while other meth-
ods lack accuracy or interpretability. In practice, we apply GIFT
to human cancer analytic using the PANCAN12 dataset and suc-
cessfully identify important relations between cancers, gene sets,
and genes. For instance, GIFT suggests influential gene sets for spe-
cific cancer (e.g., interferon-gamma response gene set for ovarian
cancer). In addition, GIFT discovers relations between cancers and
genes (e.g., BRCA cancer↔ APOA1 gene and OV, UCEC cancers
↔ BST2 gene). Furthermore, GIFT is able to extract out-of-the-box
relations, which are not given in prior information. Specifically,
in Hallmark gene set data, a CASP8AP2 gene was not included
in a gene set about apoptosis. However, GIFT elicits a relation be-
tween the gene and gene set, which is an acknowledged relation
by [11, 14].
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SUPPLEMENTARY INFORMATION
1.1 Interpretability
In this section, we offer additional experimental results of GIFT
and other methods. In detail, we first introduce several value distri-
butions of masked and unmasked entries derived by three methods
and describe scalability of the algorithms with respect to the num-
ber of observed entries in a tensor.
Figure 1 illustrates value distributions of masked and unmasked
entries derived by GIFT (λ = 100). Compared to the result offered
by the main paper (λ = 10), the gap between masked and unmasked
ones becomes much larger. Although it provides more interpretable
results, its accuracy is lower than that of the case when λ = 10.
Moreover, it is hard to reveal important masked entries when λ =
100. Thus, we use λ = 10 in the discovery section.
A B
Figure 1: Distributions of values in a gene factor matrix de-
rived byGIFT (λ = 100) for unmasked (A) andmasked entries
(B). The values of unmasked entries are much larger than
that of masked ones.
However, P-Tucker fails to make a distinction between masked
and unmasked entries, as shown in Figure 2. The results are easily
expected since P-Tucker does not differentiate the masked and
unmasked ones when it updates factor matrices.
A B
Figure 2: Distributions of values in a gene factor matrix de-
rived by P-Tucker (λ = 10)for unmasked (A) andmasked en-
tries (B). There are no clear distinctions between unmasked
and masked entries.
On the other hand, Silenced-TF produces interpretable results, as
presented in Figure 3. The values of masked entries are fixed to
zeros, while the values of unmasked entries are varying from 0 to
0.3. Although Silenced-TF provides interpretable results, it cannot
retrieve important masked entries as the values of them are set to
zeros.
1.2 Scalability
We vary the number of observable entries by randomly sampling
20%, 40%, 60%, 80%, and 100% from the PANCAN12 tensor. As shown
A B
Figure 3: Distributions of values in a gene factor matrix de-
rived by Silenced-TF (λ = 10) for unmasked (A) andmasked
entries (B). The values of masked entries are set to zeros,
while the values of unmasked entries are varying from 0 to
0.3.
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Figure 4: Scalability of P-Tucker (A) and Silenced-TF (B)
with respect to the number of observable entries in the ten-
sor. As the number of observed entries increases, a running
time of P-Tucker and Silenced-TF increases proportion-
ally.
in Figures 4, P-Tucker (A) and Silenced-TF (B) scale near linearly
in terms of the number of observable entries.
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